STOCK ALARM
SA
Menu
⌘K
Set Alert
Demo
Log In
Today
My Portfolio
Find Stocks
The Market
Charts
Research
Advisor
⌘J
ELVN
(ELVN)
ELVN
Overview
Intelligence
Chart
Fundamentals
Key Metrics
Earnings
Growth
Analysts
Financials
Insiders
Institutional
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
Enliven Therapeutics, Inc.
(ELVN)
$41.20
▼
-0.38 (-91.39%)
Chart
Share
Post on X
ELVN
Enliven Therapeutics, Inc.
(ELVN)
NASDAQ
$41.20
▼
-0.38 (-91.39%)
Chart Studio
Share
ELVN
Show Technical Panel
Show S&P 500 Navigator
Loading chart...
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$872.63M
-17.6%
P/E Ratio
-8.42
+29.3%
P/S Ratio
0.00
ROE
-22.56%
+21.5%
ROIC
-26.01%
+22.9%
FCF Yield
-8.07%
-16.8%
Debt/Equity
0.00
Current Ratio
28.66
+43.4%
Interest Coverage
0.00x
Per Share
Revenue/Share
$0.00
Net Income/Share
$-1.83
+3.2%
Operating CF/Share
$-1.24
+20.2%
Free CF/Share
$-1.24
+20.1%
Cash/Share
$8.16
+22.6%
Book Value/Share
$8.11
+23.2%
Tangible Book/Share
$8.11
+23.2%
Equity/Share
$8.11
+23.2%
Interest Debt/Share
$0.01
Valuation
Market Cap
$872.63M
-17.6%
Enterprise Value
$774.13M
-17.2%
P/E Ratio
-8.42
+29.3%
P/S Ratio
0.00
P/OCF Ratio
-12.41
+14.2%
P/FCF Ratio
-12.38
+14.4%
P/B Ratio
1.90
-44.5%
P/TB Ratio
1.90
-44.5%
EV/Sales
0.00
EV/EBITDA
-6.48
+27.7%
Profitability
Earnings Yield
-11.88%
-41.4%
FCF Yield
-8.07%
-16.8%
ROE
-22.56%
+21.5%
ROIC
-26.01%
+22.9%
Return on Tangible Assets
-21.78%
+20.3%
Capital Allocation
CapEx/OCF
-0.22%
-273.9%
CapEx/Revenue
0.00%
CapEx/Depreciation
0.60
+332.8%
SBC/Revenue
0.00%
Balance Sheet
Debt/Equity
0.00
Debt/Assets
0.00
Net Debt/EBITDA
0.82
-30.7%
Current Ratio
28.66
+43.4%
Interest Coverage
0.00x
Income Quality
0.68
-17.5%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
2996 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.12x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$7.87
+24.5%